highlights on pembro crt in high-risk locally advanced cervical cancer: the keynote-a18 study
Published 1 year ago • 2.6K plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
1:38
keynote-a18: pembrolizumab chemoradiotherapy improves os in high-risk cervical cancer
-
2:17
#esmo22 highlights on pembrolizumab with crt in locally advanced hnscc: the keynote-412 study
-
0:56
keynote-a18: pembro or placebo with chemoradiotherapy in newly diagnosed high-risk cervical cancer
-
2:26
#esmo21 highlights on pembro chemo in 1st-line metastatic cervical cancer: the keynote-826 study
-
1:14
keynote-a18: pembrolizumab with chemoradiotherapy for advanced cervical cancer
-
1:52
esmo 2022 highlights in head and neck cancer
-
2:38
pembrolizumab plus chemoradiotherapy shows clinically meaningful improvement in pfs for locally ...
-
1:16
keynote 826: pembrolizumab chemo in patients with advanced cervical cancer
-
1:37
updates in icis and adcs in cervical cancer
-
2:30
advancements in parp inhibitors for cervical cancer
-
20:43
emerging opportunities in cervical cancer
-
1:18
interlace: induction chemotherapy crt as new soc in locally advanced cervical cancer
-
1:18
incorporating immunotherapy in cervical cancer and endometrial cancer treatment: 2022 esmo florida
-
19:19
clinical results of radiation and chemoradiation therapy of locally advanced cervix..| oncology 2022
-
3:09
#esmo21 highlights on nivo ipi vs extreme in 1st-line high-risk scchn: the checkmate 651 study
-
5:13
immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer
-
7:18
keynote-826: pembrolizumab chemotherapy vs placebo chemotherapy for cervical cancer
-
3:07
linda mileshkin, esmo 2019 - phase iii outback trial in cervical cancer